Ignite Creation Date:
2025-12-25 @ 3:45 AM
Ignite Modification Date:
2025-12-26 @ 2:32 AM
Study NCT ID:
NCT01225302
Status:
COMPLETED
Last Update Posted:
2017-11-21
First Post:
2010-09-28
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of Linifanib (ABT-869) in Combination With Carboplatin/Paclitaxel in Japanese Subjects With Non-Small Cell Lung Cancer (NSCLC)
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-09
Start Date Type:
None
Primary Completion Date:
2012-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-06
Completion Date Type:
ACTUAL
First Submit Date:
2010-09-28
First Submit QC Date:
None
Study First Post Date:
2010-10-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-11-17
Last Update Post Date:
2017-11-21
Last Update Post Date Type:
ACTUAL